Business NewsMarketWire • Versartis Long-Term Preclinical Safety Data for VRS-317 Presented at ENDO 2011

Versartis Long-Term Preclinical Safety Data for VRS-317 Presented at ENDO 2011

Versartis Long-Term Preclinical Safety Data for VRS-317 Presented at ENDO 2011

Phase 1 Study of Once Monthly Human Growth Hormone Initiated in Q1/2011

View More : http://www.marketwire.com/mw/release.do?id=1522746&sourceType=3
Releted News by marketwire
Versartis Long-Term Preclinical Safety Data for VRS-317 Presented at ENDO 2011